Home › Peripheral Arterial Disease › NCT06237621

Using SnapshotNIR With Provocative Leg Maneuver for PAD Assessment

Study to Use Change in Near Infrared Spectroscopy Assessment of Tissue Oxygenation During a Provocative Leg Maneuver to Assess Peripheral Artery Disease State.

Who can join

Ages 35 to 99 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* 35-99 years of age
* Subject has at least 1 intact forefoot
* Can achieve leg positions to complete the study

Exclusion Criteria:

* The subject is unwilling or unable to comply with the protocol or scheduled appointments.
* The subject has had transmetatarsal amputation or higher on both limbs.
* Vascular intervention within the past year
* Subjects who have had a previous distal bypass procedure
* Pregnant or plans to become pregnant
* Deemed by the PI to be unsuitable for the study

About the study

The objective of this trial is to determine if Near-infrared spectroscopy (NIRS) can accurately evaluate the degree of Peripheral Arterial Disease (PAD) during a Provocative Elevation Maneuver of the Lower Extremity (PEMLE) test, as compared to routine clinical assessments.

What is being tested

• SnapshotNIR imaging (device)

Sponsor: Kent Imaging Inc · Participants: 150 · Started: Feb 12, 2024

Contact the study team

• Sunny Sajjad, DPM · Phone: (210) 567-5131

Official record on ClinicalTrials.gov — NCT06237621

Locations in the U.S.

Conditions

• Peripheral Arterial Disease

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.